Clinical research company Fortrea Holdings (NASDAQ:FTRE) missed Wall Street’s revenue expectations in Q4 CY2024, with sales ...
Discover how FTRE's $7.7B backlog, CRO market growth, and focus on high-margin areas ensure long-term growth, efficiency, and ...
StockStory.org on MSN6d
Why Fortrea (FTRE) Shares Are Plunging TodayWhat Happened? Shares of clinical research company Fortrea Holdings (NASDAQ:FTRE) fell 18.5% in the pre-market session after ...
Clinical research company Fortrea Holdings (NASDAQ:FTRE) will be reporting earnings tomorrow before market hours. Here’s what ...
Research analysts at William Blair cut their Q4 2025 earnings estimates for Fortrea in a research report issued to clients ...
Fortrea (NASDAQ:FTRE – Get Free Report) had its price objective lowered by investment analysts at Barclays from $25.00 to $12 ...
In a report released today, Max Smock from William Blair maintained a Hold rating on Fortrea Holdings Inc. (FTRE – Research Report). The ...
Zacks Investment Research on MSN6d
Fortrea Holdings Inc. (FTRE) Q4 Earnings and Revenues Miss EstimatesFortrea Holdings Inc. (FTRE) came out with quarterly earnings of $0.18 per share, missing the Zacks Consensus Estimate of $0.36 per share. This compares to earnings of $0.19 per share a year ago.
Holdings Inc trading halted, volatility trading pauseDiscover the Best Stocks and Maximize Your Portfolio: See what ...
FORTREA ($FTRE) posted quarterly earnings results on Monday, March 3rd. The company reported earnings of $0.18 per share, missing estimates of $0.37 by $0.19. The ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback